Contact us
Home / News Center / Investors

Investors

Filters
Filters
Category
Search
Show (7)
Cancel
GMP0512
Business, Investors

Bora Group to Acquire MacroGenics’ GMP Manufacturing Operations for $122.5M, Securing Maryland-Based Drug-Substance Facility and Existing Commercial Orders to Scale the Group’s Integrated Technology Platform

Taipei, Taiwan, May 12, 2026 – Bora Pharmaceuticals (“Bora” or

Banner announcing SunWay Biotech to acquire Weider Global Nutrition, with logos for SunWay Biotech and Weider Global Nutrition.
Business, Investors

Bora Group Accelerates Nutraceutical Substance CDMO Investments and Global Channel Build-Out For Brand Business

Subsidiary Sunway Biotech to Acquire Weider Global Nutrition Acquisition Completes

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
Business, Investors

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract

Bora manufactures more than 20 commercial products for GSK at

Bora-Zhunan-2-r9rm43l1jaffg866ioruef5763z1vbjprjfkrv6o6k
Business, Investors

Bora Pharmaceuticals’ Zhongli Facility Approved as a Bonded Factory, Advancing Supply Chain Efficiency

Taipei, Taiwan, February 23, 2026 – Bora Pharmaceuticals Co., Ltd.

ADR Web
Business, Investors

OTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQX

NEW YORK, (January 8, 2026) –OTC Markets Group Inc. (OTCQX:

NEWs
Events, Investors

Bora Company Presentation at 43rd Annual J.P. Morgan Healthcare Conference

43rd Annual J.P. Morgan Healthcare Conference Bora Pharmaceuticals has been

news20_42nd Annual_January 5, 2024_1523x510
Events, Investors

42nd Annual J.P. Morgan Healthcare Conference

Bora Pharmaceuticals has been invited to participate in the prestigious